Effects of human TFPI and CD47 expression and selectin and integrin inhibition during GalTKO.hCD46 pig lung perfusion with human blood

Loss of barrier function when GalTKO.hCD46 porcine lungs are perfused with human blood is associated with coagulation pathway dysregulation, innate immune system activation, and rapid sequestration of human formed blood elements. Here, we evaluate whether genetic expression of human tissue factor pathway inhibitor (hTFPI) and human CD47 (hCD47), alone or with combined selectin and integrin adhesion pathway inhibitors, delays GalTKO.hCD46 porcine lung injury or modulates neutrophil and platelet sequestration.

[1]  R. Pierson,et al.  Pig‐to‐baboon lung xenotransplantation: Extended survival with targeted genetic modifications and pharmacologic treatments , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  R. Pierson,et al.  Ex Vivo Perfusion and In Vivo Xenotransplantation of Pig Lungs with Humanized Von Willebrand Factor Demonstrate Reduced Platelet Sequestration , 2021 .

[3]  M. Tector,et al.  The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation , 2020, Frontiers in Immunology.

[4]  R. Pierson,et al.  Xenogeneic Lung Transplantation Models. , 2020, Methods in molecular biology.

[5]  R. Barth,et al.  Advances in liver xenotransplantation , 2018, Current opinion in organ transplantation.

[6]  R. Pierson,et al.  Progress and challenges in lung xenotransplantation: an update , 2018, Current opinion in organ transplantation.

[7]  T. Nagayasu,et al.  GalT‐KO pig lungs are highly susceptible to acute vascular rejection in baboons, which may be mitigated by transgenic expression of hCD47 on porcine blood vessels , 2018, Xenotransplantation.

[8]  R. Pierson,et al.  P‐ and E‐selectin receptor antagonism prevents human leukocyte adhesion to activated porcine endothelial monolayers and attenuates porcine endothelial damage , 2018, Xenotransplantation.

[9]  C. Ahn,et al.  Role of Human CD200 Overexpression in Pig-to-Human Xenogeneic Immune Response Compared With Human CD47 Overexpression , 2017, Transplantation.

[10]  H. Lee,et al.  The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages , 2017, Xenotransplantation.

[11]  K. Ley,et al.  P-selectin glycoprotein ligand-1 in T cells , 2017, Current opinion in hematology.

[12]  Misha L. Dunbar,et al.  E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model , 2017, Thrombosis and Haemostasis.

[13]  R. Pierson,et al.  Transgenic expression of human leukocyte antigen‐E attenuates GalKO.hCD46 porcine lung xenograft injury , 2017, Xenotransplantation.

[14]  E. Klein,et al.  Immunological and physiological observations in baboons with life‐supporting genetically engineered pig kidney grafts , 2017, Xenotransplantation.

[15]  S. Robson,et al.  Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[16]  R. Pierson,et al.  Platelet sequestration and activation during GalTKO.hCD46 pig lung perfusion by human blood is primarily mediated by GPIb, GPIIb/IIIa, and von Willebrand Factor , 2016, Xenotransplantation.

[17]  R. F. Hoyt,et al.  Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft , 2016, Nature Communications.

[18]  R. Pierson,et al.  Current status of pig lung xenotransplantation. , 2015, International journal of surgery.

[19]  Huanzhang Shao,et al.  rPSGL-1-Ig, a recombinant PSGL-1-Ig fusion protein, ameliorates LPS-induced acute lung injury in mice by inhibiting neutrophil migration. , 2015, Cellular and Molecular Biology.

[20]  D. Cooper,et al.  Progress in pig‐to‐non‐human primate transplantation models (1998–2013): a comprehensive review of the literature , 2014, Xenotransplantation.

[21]  R. Pierson,et al.  The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation , 2014, Xenotransplantation.

[22]  I. Wamala,et al.  Increased transfusion‐free survival following auxiliary pig liver xenotransplantation , 2014, Xenotransplantation.

[23]  D. Ayares,et al.  Expression of Human CD46 Modulates Inflammation Associated With GalTKO Lung Xenograft Injury , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  B. Østerud,et al.  Pro- and anti-inflammatory effects of histamine on tissue factor and TNFα expression in monocytes of human blood. , 2014, Thrombosis research.

[25]  H. Hara,et al.  Corneal blindness and xenotransplantation , 2014, Xenotransplantation.

[26]  R. Pierson,et al.  Activated Protein C Decreases Thrombosis onPorcine Endothelium Transgenic for Human Endothelial Protein C Receptor - A Novel Mechanism to Decrease Porcine Xenograft Injury. , 2014 .

[27]  R. F. Hoyt,et al.  One‐Year Heterotopic Cardiac Xenograft Survival in a Pig to Baboon Model , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  D. Cooper,et al.  KIDNEY XENOTRANSPLANTATION , 2013, Kidney international.

[29]  G. Snell,et al.  Sustained function of genetically modified porcine lungs in an ex vivo model of pulmonary xenotransplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  I. Wamala,et al.  Up to 9‐day survival and control of thrombocytopenia following alpha1,3‐galactosyl transferase knockout swine liver xenotransplantation in baboons , 2012, Xenotransplantation.

[31]  R. Pierson,et al.  Clinical lung xenotransplantation – what donor genetic modifications may be necessary? , 2012, Xenotransplantation.

[32]  H. Tazelaar,et al.  Human CD55 Expression Blocks Hyperacute Rejection and Restricts Complement Activation in Gal Knockout Cardiac Xenografts , 2012, Transplantation.

[33]  C. McGregor,et al.  Cardiac xenotransplantation: progress and challenges , 2012, Current opinion in organ transplantation.

[34]  K. Bondioli,et al.  Production of transgenic and knockout pigs by somatic cell nuclear transfer. , 2012, Methods in molecular biology.

[35]  K. Ley,et al.  Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. , 2011, Blood.

[36]  A. Hafezi-Moghadam,et al.  Endogenous PMN sialidase activity exposes activation epitope on CD11b/CD18 which enhances its binding interaction with ICAM‐1 , 2011, Journal of leukocyte biology.

[37]  N. Navarro-Alvarez,et al.  CD47: a new player in phagocytosis and xenograft rejection , 2011, Cellular and Molecular Immunology.

[38]  D. Sachs,et al.  Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection , 2011, Xenotransplantation.

[39]  B. Hering,et al.  Pig-to-nonhuman primate islet xenotransplantation. , 2009, Transplant immunology.

[40]  D. Sachs,et al.  Rejection of Cardiac Xenografts Transplanted from α1,3‐Galactosyltransferase Gene‐Knockout (GalT‐KO) Pigs to Baboons , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  S. Robson,et al.  Recombinant pig TFPI efficiently regulates human tissue factor pathways , 2008, Xenotransplantation.

[42]  H. Kang,et al.  Pre‐treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex‐vivo model of swine‐to‐human pulmonary xenotransplantation , 2008, Xenotransplantation.

[43]  D. Cooper,et al.  Recent advances in pig-to-human organ and cell transplantation , 2008, Expert opinion on biological therapy.

[44]  Hideki Ohdan,et al.  Role for CD47-SIRPα signaling in xenograft rejection by macrophages , 2007, Proceedings of the National Academy of Sciences.

[45]  G. Gonzalez-Stawinski,et al.  Depletion of Pulmonary Intravascular Macrophages Prevents Hyperacute Pulmonary Xenograft Dysfunction , 2006, Transplantation.

[46]  G. Shaw,et al.  Molecular Characterization of Rat Leukocyte P-Selectin Glycoprotein Ligand-1 and Effect of Its Blockade: Protection from Ischemia-Reperfusion Injury in Liver Transplantation1 , 2006, The Journal of Immunology.

[47]  F. Gao,et al.  Disruption of P-Selectin Signaling Modulates Cell Trafficking and Results in Improved Outcomes after Mouse Warm Intestinal Ischemia and Reperfusion Injury , 2005, Transplantation.

[48]  C. Legrand,et al.  Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis. , 2005, Anticancer research.

[49]  T. Matozaki,et al.  Negative Regulation of Phagocytosis in Macrophages by the CD47-SHPS-1 System1 , 2005, The Journal of Immunology.

[50]  S. Bhattacharya,et al.  Anti-inflammatory effect of intraventricularly administered histamine in rats , 1985, Agents and Actions.

[51]  Z. Ruggeri,et al.  The role of the porcine von willebrand factor: baboon platelet interactions in pulmonary xenotransplantation , 2002, Transplantation.

[52]  Yifan Dai,et al.  Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs , 2002, Nature Biotechnology.

[53]  Y. Merhi,et al.  P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces. , 2001, The Journal of pharmacology and experimental therapeutics.

[54]  R. Pierson,et al.  Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection. , 2001, Journal of applied physiology.

[55]  H. Yagita,et al.  The β2, α4, α5 Integrins and Selectins Mediate Chemotactic Factor and Endotoxin-Enhanced Neutrophil Sequestration in the Lung , 2001 .

[56]  D. Dietzen,et al.  Tissue Factor Pathway Inhibitor Binds to Platelet Thrombospondin-1* , 2000, The Journal of Biological Chemistry.

[57]  K. Ley,et al.  Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin , 2000, Critical care medicine.

[58]  R. Lechler,et al.  Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins. , 1999, Transplantation.

[59]  R. Schaub,et al.  Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. , 1999, Circulation.

[60]  A. M. Lefer,et al.  Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. , 1999, Cardiovascular research.

[61]  M. Carraway,et al.  Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons. , 1998, American journal of respiratory and critical care medicine.

[62]  R. Lechler,et al.  Human Tissue Factor Pathway Inhibitor Fused to CD4 Binds both FXa and TF/FVIIa at the Cell Surface , 1997, Thrombosis and Haemostasis.

[63]  R. Pierson,et al.  Thromboxane mediates pulmonary vasoconstriction and contributes to cytotoxicity in pig lungs perfused with fresh human blood. , 1996, Transplantation Proceedings.

[64]  A. M. Lefer,et al.  Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. , 1995, Blood.

[65]  D H Sachs,et al.  The pig as a potential xenograft donor. , 1994, Veterinary immunology and immunopathology.

[66]  H. Gresham,et al.  An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors. , 1989, Journal of immunology.